Sodium Sulfacetamide 9.8%, Sulfur 4.8%
Product Images NDC 42582-801

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sodium Sulfacetamide 9.8%, Sulfur 4.8% (NDC 42582-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bi-coastal Pharma International Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Spl Image1 Label)

This is a topical medication indicated for the control of acne vulgaris, acne rosacea, and seborrheic dermatitis. It contains sodium sulfacetamide (9.8%) and sulfur (4.8%) along with other ingredients. The medication is contraindicated in patients with hypersensitivity to sulfonamides, sulfur, or any component of the product, as well as patients with kidney disease. It is for external use only and must not be used in the eyes or mucous membranes. The medication should be stored at 20°C to 25°C and kept away from children. It is manufactured by Bi-Coastal Pharma International LLC.*

FDA Label Image

Image Description (Spl Image1 Structure1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.